It was first identified by researchers at Harvard in 1987, when scientists Mojsov, Weir, and Habener discovered it was produced in the gut and powerfully triggered insulin release
It helps determine whether a patient is ready for a dose increase or if they should remain at their current level for a bit longer
The degree to which autophagy induction leads to observable enhancements in human metabolic health, especially among individuals with T2DM or metabolic syndrome, is still not fully understood [27]
And it also reduced the operating hours in some 1,100 stores
Kwatra S, Taneja G, Nasa N (2012) Alternative routes of drug administration- transdermal, pulmonary & parenteral
A meta-analysis revealed that individuals with T2DM exhibit reduced global brain volume and regional atrophy in areas such as the hippocampus, basal ganglia, and orbitofrontal and occipital lobes [100]